systematically to underestimate the proportion of Hb 5, it should not be used for this purpose.
Materials and Methods

Results and DiscussIon
Erythrocyte hemolysate labeled in the presence of increasing concentrations of ['HI-or [14Clfolate was subjected to gel filtration.
Two typical elution diagrams are shown in Figure 1 . The peak eluted at 340 mL elution volume represents protein-bound ['H]folate; the large peak at 500 mL elution volume represents unbound ['Hifolate.
As can be seen, hemoglobin co-elutes with the first peak. Other chromatographic runs showed that the relative protein binding of folate, as assessed by integration of the peaks, was rather constant (2-3%) over a wide folate concentration range (10 nmol/L to 1 mmol/L).
Hemolysate was applied to an anion-exchange column and eluted with a low salt concentration (30 mmol/L NaC1) at pH 6.3. The effluent, which contained visible amounts of hemoglobin, was labeled with ['H]folate before gel filtration.
The elution profile (Figure 2 ) was similar to that of Figure 1 . CLIN. CHEM. 27 /7, 1249-1254 (1981) 12. HoIm, J., Hansen, S. I., and Lyngbye, J., Characterization and identification of low-affinity folate binding proteins in human serum. IRCS Med. Sci. 8,840-841(1980 Radioimmunoassays for haloperidol are described, involving use of tritium-or 125l-lled drug or tritium-labeled spiroperidol, and a rabbit antiserum to a drug/bovine serum albumin conjugate. The '25l-labeled drug was prepared by the Chloramine T iodination technique. A fluoroimmunoassay for haloperidol is also described in which the antiserum is coupled to magnetizable solid-phase medium, and fluorescein-labeled haloperidol is used. The assays have acceptable accuracy, precision, and reproducibility, and are specific for haloperidol and similar butyrophenones, with no significant interference from known metabolites and other drugs. Only the radioimmunoassays have sufficient sensitivity to cover the whole range of haloperidol concentrations in serum. The fluoroimmunoassay can be used to monitor high concentrations of haloperidol in 15O-i.tL samples or the complete concentration range of 1-mL serum samples that are extracted and concentrated before assay.
